Definitive Healthcare Corp

Definitive Healthcare Corp(DH)股票分析

$1.125

-0.096 (-8.54%)收盤時

Loading chart…
最高
1.232
開盤
1.230
成交量加權均價
1.14
成交量
619.15K
市值
625.05M
最低
1.050
成交金額
703.07K
企業價值/稅息折舊攤銷前利潤(TTM)
3.35

Definitive Healthcare Corp. is engaged in transforming data, analytics, and expertise into healthcare commercial intelligence. The Company’s solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. It transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. Its business is conducted through AIDH TopCo, LLC (Definitive OpCo).

AI 分析 of Definitive Healthcare Corp (DH)

買進

Definitive Healthcare Corp (DH) is a good buy right now due to its current price of $1.13 being above the recent acquisition interest price of $1.02 per share, indicating potential upside. The stock has shown a positive trend with a 5-day change of +4.63% and a 20-day change of +14.58%, suggesting increasing investor interest. However, the main risk is the significant year-to-date decline of -52.42%, reflecting ongoing challenges in profitability.

估值指標

Definitive Healthcare Corp(DH)目前預期本益比為 5.97,5 年平均預期本益比為 38.08。

預期本益比

合理
5 年均值 P/E
38.08
目前P/E
5.97
高估
74.79
低估
1.36

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
17.62
目前EV/EBITDA
3.35
高估
32.56
低估
2.69

預期股價營收比

合理
5 年均值 P/S
3.97
目前P/S
0.57
高估
7.50
低估
0.45

Alphio AI 對 DH 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%DH

$3.73

情境價格

基

基準

基準 · 50%DH

$3.39

情境價格

悲

悲觀

悲觀 · 25%DH

$3.31

情境價格

持有 DH 的大戶

A

Advent International, L.P.

+ 持有DH

+3.43%

3個月報酬率

事件時間軸

2026-11-05 (ET)

17:30:00

Definitive Healthcare Reports Q3 Revenue of $54.65M

2026-11-04 (ET)

13:30:00

Definitive Healthcare Expands Leadership Team with New CPO and SVP of AI and Data

2026-09-02 (ET)

09:30:00

Definitive Healthcare Receives Acquisition Interest from Advent International

09:00:00

Definitive Healthcare Appoints Clay Ritchey as New CEO

2026-08-10 (ET)

17:00:00

Consensus 18c Narrows FY26 Revenue Outlook to $220M

資訊

DH 常見問題 —— 由 Alphio AI 解答

Definitive Healthcare Corp. is engaged in transforming data, analytics, and expertise into healthcare commercial intelligence. The Company’s solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. It transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. Its business is conducted through AIDH TopCo, LLC (Definitive OpCo). It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).

Definitive Healthcare Corp (DH) is a good buy right now due to its current price of $1.13 being above the recent acquisition interest price of $1.02 per share, indicating potential upside. The stock has shown a positive trend with a 5-day change of +4.63% and a 20-day change of +14.58%, suggesting increasing investor interest. However, the main risk is the significant year-to-date decline of -52.42%, reflecting ongoing challenges in profitability.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易